PatientsVille.com Logo

DEATH and Endocet

PatientsVille

DEATH Symptoms and Causes

Sudden infant Death syndrome (SIDS) is the sudden, unexplained Death of an infant younger than one year old. Some people call SIDS "crib Death" because many babies who die of SIDS are found in their cribs.

SIDS is the leading cause of Death in children between one month and one year old. Most SIDS Deaths occur when babies are between one month and four months old. Premature babies, boys, African Americans, and American Indian/Alaska Native infants have a higher risk of SIDS.

Although health care professionals don't know what causes SIDS, they do know ways to reduce the risk. These include

  • Placing your baby on his or her back to sleep, even for short naps. "Tummy time" is for when babies are awake and someone is watching
  • Having your baby sleep in your room for at least the first six months. Your baby should sleep close to you, but on a separate surface designed for infants, such as a crib or bassinet.
  • Using a firm sleep surface, such as a crib mattress covered with a fitted sheet
  • Keeping soft objects and loose bedding away from your baby's sleep area
  • Breastfeeding your baby
  • Making sure that your baby doesn't get too hot. Keep the room at a comfortable temperature for an adult.
  • Not smoking during pregnancy or allowing anyone to smoke near your baby

NIH: National Institute of Child Health and Human Development

Check out the latest treatments for DEATH

DEATH treatment research studies

Endocet clinical trials, surveys and public health registries


Find Drug Side Effect reports



Endocet Side Effects

Nausea (11)
Abdominal Pain Upper (7)
Diarrhoea (6)
Asthenia (5)
Abdominal Discomfort (5)
Insomnia (5)
Loss Of Consciousness (5)
Pruritus (5)
Vomiting (5)
Dizziness (4)
Decreased Appetite (4)
Fatigue (4)
Product Substitution Issue (4)
Headache (4)
Pain (4)
Feeling Jittery (3)
Constipation (3)
Hyperhidrosis (3)
Anxiety (3)
Migraine (3)
Malaise (3)
Renal Pain (3)
Somnolence (3)
Overdose (3)
Weight Increased (2)
Abdominal Distension (2)
Influenza (2)
Lethargy (2)
Abdominal Pain (2)
Local Swelling (2)
Chest Pain (2)
Crying (2)
Vision Blurred (2)
Convulsion (2)
Contusion (2)
Bronchopneumonia (2)
Arthralgia (2)
Panic Attack (2)
Mood Swings (2)
Memory Impairment (2)
Myocardial Infarction (2)
Nightmare (2)
Pain In Extremity (2)
Pharyngeal Oedema (2)
Product Formulation Issue (2)
Restlessness (2)
Rash (2)
Pyrexia (2)
Product Quality Issue (2)
Urticaria (2)

➢ More


Common Meds

Abilify (10132)
Adderall (1304)
Amlodipine (6664)
Amoxicillin (4387)
Benadryl (1568)
Celebrex (12876 )
Celexa (1342)
Cialis (2975)
Cipro (8580)
Citalopram (7792)
Crestor (18839)
Cymbalta (14373)
Doxycycline (1757)
Effexor (7289)
Flexeril (435)
Flomax (2177)
Fluoxetine (4261)
Gabapentin (4593)
Hydrocodone (2469)
Ibuprofen (8222)
Lantus (10968)
Lexapro (3499)
Lipitor (17769)
Lisinopril (8919)
Lyrica (27148)
Medrol (650)
Mirena (41254)
Mobic (957)
Morphine (5356)
Naproxen (538)
Neurontin (6501)
Oxycodone (4438)
Pradaxa (13372)
Prednisone (5926)
Prilosec (2631)
Prozac (1954)
Seroquel (27216)
Simvastatin (8348)
Synthroid (4452)
Tamiflu (5585)
Topamax (3748)
Tramadol (5054)
Trazodone (1458)
Viagra (5394)
Vicodin (1153)
Wellbutrin (6324)
Xanax (2847)
Zocor (5718)
Zoloft(6792)
Zyrtec(1669)

Recent Reviews

Brother age 30 dies 1974 and death certificate read vicerol congestion. No apparent sickness ,ate before he went to bed never woke up.

I have just come back from a funeral for my brother. He was just 62. He was on statin medicine but his cholestrol, blood pressure, weight and diet was very much in control. In fact just a day before his death the doctor told him that he was doing f

.. Worry over whether I'll be accepted by students and colleagues as normal, OPK, even competenty. 2. Worry about death of pets, spouse, getting critically ill myself 3. Dissatisfaction wqith the job I do teaching and that student

After 3 days of taking the Zicam Rapid Melts religiously, I was terrified to see my sink FULL of blood while brushing my teeth...needless to say it scared me to death and I will stop taking this medication ASAP!

Am a resident and saw my first death from pradaxa this past week. we tried everything including dialysis and he just kept bleeding....i am not going to use it unless they come up with a better way to reverse it.

Brother age 30 dies 1974 and death certificate read vicerol congestion. No apparent sickness ,ate before he went to bed never woke up.

Brought my uncle to sudden death...

DOES CIPROFLOXACI CAUSE DEATH OR IT SOME RELATED ISSNESS

Exactly whats happened to my Grandmother in Sacramento February! 7 months now after she nearly had zero blood left 2 times requiring intensive care and multi transfusions of blood to came back from what was a sure death!

Heart failure tongue swollen feeding tube so I don't choke to death

How can you check off that you experinced death from Benefiber??!!

DEATH Clinical Trials and Studies

Treatments might be new drugs or new combinations of drugs, new surgical procedures or devices, or new ways to use existing treatments. The goal of clinical trials is to determine if a new test or treatment works and is safe. Clinical trials can also look at other aspects of care, such as improving the quality of life for people with chronic illnesses. People participate in clinical trials for a variety of reasons. Healthy volunteers say they participate to help others and to contribute to moving science forward. Participants with an illness or disease also participate to help others, but also to possibly receive the newest treatment and to have the additional care and attention from the clinical trial staff.
Rank Status Study
1 Recruiting Post Traumatic Stress Among Relatives of Brain-dead, Withdrawal of Life Support, and Sudden Death Patients
Condition: Stress Disorders, Post-Traumatic
Intervention: Other: IES-R and HDAS scores
Outcome Measures: IES-R > 37: yes/no;   IES-R;   HDAS score
2 Recruiting Comparative Evaluation of IRM and Autopsy in the Evaluation of Intra Uterine Fetal Death
Condition: Spontaneous Intra Uterine Fetal Death
Intervention: Other: Comparaison between MR and autopsy in the macroscopic evaluation of intra uterine Death.
Outcome Measures: Recognition of anatomic cerebral structures evaluated by a common grid.;   Recognition and mesurement of anatomic thoracic and abdominal structures by a common grid.;   Recognition and mesurement of the placenta and umbilical cord.;   Comparaison of quality criteria of both exams.
3 Recruiting Sudden Cardiac Death - Screening Of Risk Factors
Conditions: Sudden Cardiac Death;   Cardiomyopathies;   Channelopathies
Intervention: Other: ECG and survey screening
Outcome Measures: Type 1 electrocardiogram;   Clinical History - Red Flag;   all-cause mortality;   Cardiovascular Death
4 Not yet recruiting Study of Paced QRS Duration as a Marker of Sudden Cardiac Death
Condition: Sudden Cardiac Death
Intervention:
Outcome Measure: Sudden Cardiac Death
5 Recruiting Vest Prevention of Early Sudden Death Trial and VEST Registry
Conditions: Myocardial Infarction;   Ventricular Dysfunction;   Sudden Death;   Ventricular Tachycardia;   Ventricular Fibrillation
Intervention: Device: wearable defibrillator
Outcome Measures: Sudden Death mortality;   Cardiovascular, all-cause, and other cause specific mortality;   incidence of ventricular arrhythmias;   adverse events attributable to wearable defibrillator use;   compliance with wearable defibrillator use
6 Recruiting Imaging Techniques for Identifying Factors of Sudden Cardiac Death Risk
Condition: Sudden Cardiac Death
Intervention:
Outcome Measures: sudden cardiac Death;   cardiovascular Death;   appropriate ICD discharge;   composite sudden cardiac Death and appropriate ICD discharge;   heart failure admission
7 Recruiting Epidemiology of Sudden Death in Cameroon
Condition: Cardiovascular Diseases
Intervention:
Outcome Measure: Sudden Death, either cardiac or non-cardiac origin
8 Recruiting Inflammation, Cardiac Sympathetic Innervation, and Arrhythmic Sudden Death
Conditions: Ischemic Cardiomyopathy;   Dilated Cardiomyopathy;   Inflammation;   Sudden Cardiac Death
Intervention:
Outcome Measures: Determine if inflammation is associated with abnormal cardiac sympathetic innervation in patients enrolled in the PROSE-ICD study.;   Determine if inflammation, measured by IL-6, is associated with abnormal cardiac sympathetic innervation, measured by MIBG imaging;   Examine the combination of CRP and MIBG to predict ICD therapies in PROSE-ICD;   Compare several MIBG imaging metrics of sympathetic innervation, in addition to the late H/M ratio, including the early H/M ratio and the MIBG washout rate, in regards to their association with biomarkers of inflammation (CRP and IL-6).
9 Unknown  Do Pacifiers Protect From Sudden Infant Death Syndrome (SIDS) Through an Increase in Upper Airway Patency?
Condition: Sudden Infant Death
Intervention:
Outcome Measure: Upper airway caliber and patency
10 Recruiting Clinical Registry on Sudden Death Primary Prevention at Latin America
Conditions: Myocardial Infarction;   Sudden Death
Intervention: Procedure: Implantable Cardio Defibrillator (ICD),
Outcome Measures: Prevalence of patients with MADIT, MADIT II and MUST at Latin American countries;   Study incidence of Arrhythmic mortality and serious arrhythmic events, evaluated through remote monitoring
11 Recruiting Computed Tomography Angiography to Brain Death Assessment
Condition: Brain Death
Intervention:
Outcome Measure: Assess the presence or absence of contrast medium filling of the intracranial vessels in comatose patients.
12 Not yet recruiting Amiodarone Against ICD Therapy in Chagas Cardiomyopathy for Primary Prevention of Death
Conditions: Chagas Cardiomyopathy;   Non-sustained Ventricular Tachycardia;   At Least 10 Points in Rassi Risk Score for Death
Interventions: Procedure: ICD implantation;   Drug: amiodarone hydrochloride
Outcome Measures: all cause mortality;   Cardiac mortality;   Sudden cardiac Death;   Worsening heart failure warranting hospitalization;   Need for cardiac stimulation in the ICD arm;   Need for pacemaker implantation in the amiodarone therapy arm
13 Recruiting MAP-IDM: Identification of Molecular Markers of Sudden Death at the Acute Phase of Myocardial Infarction
Condition: Myocardial Infarction
Intervention: Genetic: Blood sample
Outcome Measure: Correlation phenotype/genotype of sudden Death at the acute phase of myocardial infarct.
14 Recruiting Using Ongoing Newborn Intervention Trials to Obtain Additional Data Critical to Maternal, Fetal and Newborn Health in a Harmonized Way
Conditions: Maternal Deaths;   Neonatal Deaths;   Still Births
Intervention: Other: This is an observational study being conducted as a substudy of antoher trial.
Outcome Measures: Burden of maternal and neonatal Death and still births;   Timing of maternal and neonatal Death and still births;   Causes of maternal and neonatal Death and still births
15 Recruiting Deceased Donor Biomarkers and Recipient Outcomes
Conditions: Deceased Donor Kidney Transplant;   Acute Kidney Injury;   Delayed Graft Function;   End Stage Renal Disease;   Graft Failure
Intervention:
Outcome Measures: Delayed Graft Function;   Death-Censored Graft Failure;   Graft Function
16 Unknown  Prospective Observational Study of the ICD in Sudden Cardiac Death Prevention
Conditions: Heart Failure, Congestive;   Death, Sudden, Cardiac;   Arrhythmia;   Cardiomyopathies
Intervention:
Outcome Measures: Arrhythmic Sudden Death defined as a shock from the ICD for rapid VT or VF or a ventricular arrhythmia not corrected by the ICD;   All cause mortality, CV mortality, heart transplant, ICD explantation
17 Recruiting Cardiac Rhythm Abnormalities in Patients With Refractory Epilepsy at High Risk for Sudden Death
Conditions: Refractory Epilepsy;   Arrhythmia;   Sudden Death
Intervention: Device: Medtronic REVEAL
Outcome Measure:
18 Recruiting Left Ventricular Structural Predictors of Sudden Cardiac Death
Conditions: Ischemic Cardiomyopathy;   Nonischemic Cardiomyopathy
Intervention:
Outcome Measures: Composite SCD outcomes;   Composite cardiac outcomes
19 Recruiting Adequate Definition of Delayed Graft Function in Living and Deceased Donor Kidney Transplantation
Conditions: Deceased Donor Kidney Transplantation;   Living Donor Kidney Transplantation
Intervention: Procedure: kidney transplantation, living or deceased donor
Outcome Measures: delayed graft function as defined by dialysis requirements within one week after transplantation;   delayed graft function as defined by urine output less than1200 ml during first day after transplantation;   delayed graft function as defined by serum creatinine decrease less than 10% during 48 hours after transplantation;   delayed graft function as defined by creatinine greater than 2.5 mg/dL at ten days after transplantation;   delayed graft function as defined by creatinine clearance less than 10 ml/min/1.73m2 during 24 hours after transplantation;   delayed graft function as defined by creatinine did not decrease less than preoperative value
20 Unknown  End-of-Life Fear in Patients With End-Stage Lung Disease (COPD)
Conditions: Chronic Obstructive Pulmonary Disease;   End-of-Life Fear;   Fear About Death and Dying;   Depression
Intervention: Behavioral: A brief psycho-educational intervention
Outcome Measures: Self-reported semi-structured interview about the fear of Death and dying, needs and wishes at the end-of-life in patients with severe COPD;   St. George's Respiratory Questionnaire (SGRQ);   Short Form Health Survey (Fragebogen zum allgemeinen Gesundheitszustand, SF-36);   Euroqol (EQ);   Patient Health Questionnaire (PHQ);   Hospital Anxiety and Depression Scale (HADS);   Borg Scale;   Diffusion capacity (DLCO);   Blood gas analysis (BGA);   Bodyplethysmographs;   Bio-Impedance-Analysis (BIA);   6-Minute Walk Distance (6 MWD);   Body Mass Index (BMI);   Blood tests;   Multidimensional assessment of attitudes toward Death and dying (Fragebogeninventar zur mehrdimensionalen Erfassung des Erlebens gegenüber Sterben und Tod, FIMEST);   COPD- Anxiety -Questionnaire (COPD-Angst-Fragebogen, CAF);   COPD- Disability- Index (CDI);   Differences in COPD admission rates, functional impairment, quality of life and end-of-life fear after treatment